FY26-27 Adult Covid-19 Vaccines
Overview
- Posted
- June 3, 2026
- Notice type
- Award Notice
- Agency
- Department of Health and Human ServicesCENTERS FOR DISEASE CONTROL AND PREVENTION
Notice details
- Office
- CDC OFFICE OF ACQUISITION SERVICES
- Place of performance
- Atlanta, Georgia, 30341
- Last updated
- Oct 29, 2026
- First published
- Last updated on SAM.gov
- Award date
- Jun 1, 2026
- Award amount (SAM.gov award notice)
- $505.3M
Identifiers
- Solicitation number
- 75D30126R73405
- Notice ID
- 0377009585864cf58dbd7a3fe3f55414
- Award number (PIID)
- 75D30126D21004
Description
The Centers for Disease Control and Prevention (CDC) awards one or more Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts for the purchase of standard commercial adult vaccines.
Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The establishment of these contracts provides opportunity to utilize Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. These funds provide vaccines for state and local health departments to use in populations at greatest risk for under vaccination and disease. The 317 program, as established under Section 317(j) of the Public Health Service Act, works to ensure that adults receive appropriate immunization by partnering with healthcare providers in the public and private sectors. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. The vaccines awarded under these contracts will be purchased for the National Center for Immunization and Respiratory Disease’s (NCIRD’s) immunization awardees (the fifty state health departments, several large city programs, and current and former U.S. Territories) to support adult immunization programs as provided under Section 317(j) of the Public Health Service Act. In addition, awardees may opt to purchase additional quantities of vaccine for adults under any resulting contract using state and local funds.
While the primary intention for the contracts is to procure vaccines for the 2026-2027 season, the government also has a requirement to be able to purchase vaccines for the 2025-2026 season, before vaccine becomes available for the 2026-2027 season.
Award Overview
Award Number
75D30126D21004
Award Amount (SAM.gov award notice)
$505.3M
Award Date
Jun 1, 2026
Awardee
Awardee Address
New York, NY 10001, UNITED STATES
Original Solicitation
Notice ID: 0377009585864cf58dbd7a3fe3f55414
Posted Date: Jun 3, 2026
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- $5.3MSigned Oct 23, 2026
- $768.9MSigned Oct 23, 2026
- $8.4MSigned Oct 5, 2026
- $45.5MSigned Aug 28, 2026
- $45.5MSigned Aug 21, 2026
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
Showing 4 of 4 items
Document | Source | Agency | Posted Date | File Size | Actions | |
|---|---|---|---|---|---|---|
| Combined Synopsis/Solicitation | CENTERS FOR DISEASE CONTROL AND PREVENTION | Jun 3, 2026 | 24.09 KB | |||
| Combined Synopsis/Solicitation | CENTERS FOR DISEASE CONTROL AND PREVENTION | Jun 3, 2026 | 22.16 KB | |||
| Combined Synopsis/Solicitation | CENTERS FOR DISEASE CONTROL AND PREVENTION | Jun 3, 2026 | 85.78 KB | |||
| Combined Synopsis/Solicitation | CENTERS FOR DISEASE CONTROL AND PREVENTION | Jun 3, 2026 | 586.91 KB |
Lifecycle
- 3Version 3Award NoticeArchivedCurrent
FY26-27 Adult Covid-19 Vaccines
Other notices for this solicitation
- Combined SynopsisRelated noticeMar 4, 2026
FY26-27 Adult Covid-19 Vaccines
- AwardedRelated noticeJun 3, 2026
FY26-27 Adult Covid-19 Vaccines
- AwardedRelated noticeJun 3, 2026
FY26-27 Adult Covid-19 Vaccines
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75D30126R73405
Archive Date
Jun 16, 2026
Office Address
ATLANTA, GA, 30333